These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18387052)

  • 1. Emerging health economics and outcomes research in the Asia-Pacific region.
    Liu GG; Eggleston K; Hu TW
    Value Health; 2008 Mar; 11 Suppl 1():S1-2. PubMed ID: 18387052
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-care systems and pharmacoeconomic research in Asia-Pacific region.
    Tarn YH; Hu S; Kamae I; Yang BM; Li SC; Tangcharoensathien V; Teerawattananon Y; Limwattananon S; Hameed A; Aljunid SM; Bapna JS
    Value Health; 2008 Mar; 11 Suppl 1():S137-55. PubMed ID: 18387058
    [No Abstract]   [Full Text] [Related]  

  • 3. Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.
    Yang BM; Lee K
    Value Health; 2009; 12 Suppl 3():S1-2. PubMed ID: 20586968
    [No Abstract]   [Full Text] [Related]  

  • 4. Bridging the gap in pharmacoeconomics and outcomes research between researchers, policymakers, and practitioners in the Asia-Pacific region.
    Kulsomboon V; Yang BM; Hu S
    Value Health; 2012; 15(1 Suppl):S1-2. PubMed ID: 22265053
    [No Abstract]   [Full Text] [Related]  

  • 5. What is next for pharmacoeconomics and outcomes research in Asia?
    Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM
    Value Health; 2004; 7(2):118-32. PubMed ID: 15164802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" market.
    Hay JW; Yu WM
    Value Health; 2000; 3(3):181-5. PubMed ID: 16464182
    [No Abstract]   [Full Text] [Related]  

  • 7. Health economics--what the nephrologist should know.
    Palmer AJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1038-41. PubMed ID: 15840678
    [No Abstract]   [Full Text] [Related]  

  • 8. Organised sector: strategy for implementing family welfare programme.
    Sawhney N
    POPCEN Newsl; 1978 Jan; 3(11):8-16. PubMed ID: 12157728
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.
    Kozma CM; Reeder CE; Schulz RM
    Clin Ther; 1993; 15(6):1121-32; discussion 1120. PubMed ID: 8111809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 7th Annual International Meeting. May 19-22, 2002. Arlington, Virginia, USA. Abstracts.
    Value Health; 2002; 5(3):117-294. PubMed ID: 12010559
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region.
    Chen Y; Schweitzer SO
    Value Health; 2008 Mar; 11 Suppl 1():S124-9. PubMed ID: 18387056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a need for standardization of methods in economic evaluations of medicine?
    Rittenhouse BE
    Med Care; 1996 Dec; 34(12 Suppl):DS13-22. PubMed ID: 8969311
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacoeconomic and Outcomes Research are steadily moving forward in Asia.
    Value Health Reg Issues; 2016 May; 9():112. PubMed ID: 27881252
    [No Abstract]   [Full Text] [Related]  

  • 14. ISPOR 4th Asia-Pacific Conference. Abstracts.
    Value Health; 2010 Nov; 13(7):A502-73. PubMed ID: 21284133
    [No Abstract]   [Full Text] [Related]  

  • 15. The Hanover Consensus: helpful for German decision-makers?
    Kolominsky-Rabas PL; Caro JJ
    Value Health; 2008; 11(4):545-6; discussion 547-8. PubMed ID: 18489522
    [No Abstract]   [Full Text] [Related]  

  • 16. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 17. Renewal of our value in health mission and policy as we enter our fourth year.
    Value Health; 2001; 4(1):1-4. PubMed ID: 11704967
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations of a traveling pharmacist. Part 2.
    Olson C
    Am J Hosp Pharm; 1982 Jun; 39(6):1051-6. PubMed ID: 7102692
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Second Latin America Conference. September 2009. Brazil.
    Value Health; 2011; 14(5 Suppl 1):S1-150. PubMed ID: 21998840
    [No Abstract]   [Full Text] [Related]  

  • 20. Showcasing pharmaceutical economics, outcomes, and health policy: an update in clinical therapeutics.
    Lau DT
    Clin Ther; 2013 Apr; 35(4):354-5. PubMed ID: 23522659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.